Clinical Trial Update: A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel/carboplatin with or without CDP791 in non-squamous non-small cell lung cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CDP791 (CDP791)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: UCB Pharma | Conditions: Carcinoma, Non-Squamous Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-04-12